The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Annels, N. E.
Right arrow Articles by Rickinson, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Annels, N. E.
Right arrow Articles by Rickinson, A. B.
The Journal of Immunology, 2000, 165: 4831-4841.
Copyright © 2000 by The American Association of Immunologists

Changing Patterns of Dominant TCR Usage with Maturation of an EBV-Specific Cytotoxic T Cell Response1

Nicola E. Annels*, Margaret F. C. Callan{dagger}, Linda Tan{dagger} and Alan B. Rickinson2,*

* Cancer Research Campaign Institute for Cancer Studies and Medical Research Council Centre for Immune Regulation, University of Birmingham, Edgbaston, Birmingham, United Kingdom; and {dagger} Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom

Infection with EBV provides a unique opportunity to follow the human CD8+ T cell response to a persistent, genetically stable agent from the primary phase, as seen in infectious mononucleosis (IM) patients, into long-term memory. This study focuses on the response to an immunodominant HLA-A2.01-restricted epitope, GLCTLVAML, from the EBV-lytic cycle Ag BMLF1. TCR analysis of the highly amplified primary response to this epitope revealed markedly oligoclonal receptor usage among in vitro-derived clones, with similar clonotypes dominant in all three IM patients studied. Direct staining of IM T cell preparations with the A2.01/GLCTLVAML tetramer linked this oligoclonal epitope-specific response with appropriate Vß subset expansions in the patients’ blood. These patients were studied again >2 years later, at which time TCR analysis of in vitro-reactivated clones suggested that rare clonotypes within the primary response had now come to dominate memory. Five additional A2.01-positive IM patients were studied prospectively for Vß subset representation within primary and memory epitope-specific populations as identified by tetramer staining. In each case, the primary response contained large Vß2, Vß16, or Vß22 components, and in three of five cases the originally dominant Vß was represented very poorly, if at all, in memory. We conclude 1) that an EBV epitope-specific primary response large enough to account for up to 10% CD8+ T cells in IM blood may nevertheless be dominated by just a few highly expanded clonotypes, and 2) that with persistent viral challenge such dominant T cell clonotypes may be lost and replaced by others in memory.




This article has been cited by other articles:


Home page
J. Immunol.Home page
V. Venturi, H. Y. Chin, T. E. Asher, K. Ladell, P. Scheinberg, E. Bornstein, D. van Bockel, A. D. Kelleher, D. C. Douek, D. A. Price, et al.
TCR {beta}-Chain Sharing in Human CD8+ T Cell Responses to Cytomegalovirus and EBV
J. Immunol., December 1, 2008; 181(11): 7853 - 7862.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Venturi, H. Y. Chin, D. A. Price, D. C. Douek, and M. P. Davenport
The Role of Production Frequency in the Sharing of Simian Immunodeficiency Virus-Specific CD8+ TCRs between Macaques
J. Immunol., August 15, 2008; 181(4): 2597 - 2609.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Derre, M. Bruyninx, P. Baumgaertner, E. Devevre, P. Corthesy, C. Touvrey, Y. D. Mahnke, H. Pircher, V. Voelter, P. Romero, et al.
In Vivo Persistence of Codominant Human CD8+ T Cell Clonotypes Is Not Limited by Replicative Senescence or Functional Alteration
J. Immunol., August 15, 2007; 179(4): 2368 - 2379.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. N. Akbar and M. Vukmanovic-Stejic
Telomerase in T Lymphocytes: Use It and Lose It?
J. Immunol., June 1, 2007; 178(11): 6689 - 6694.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. Somma, G. Ristori, L. Battistini, S. Cannoni, G. Borsellino, A. Diamantini, M. Salvetti, R. Sorrentino, and M. T. Fiorillo
Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis
J. Leukoc. Biol., March 1, 2007; 81(3): 696 - 710.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Kasprowicz, A. Isa, K. Jeffery, K. Broliden, T. Tolfvenstam, P. Klenerman, and P. Bowness
A Highly Restricted T-Cell Receptor Dominates the CD8+ T-Cell Response to Parvovirus B19 Infection in HLA-A*2402-Positive Individuals.
J. Virol., July 1, 2006; 80(13): 6697 - 6701.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Sauce, M. Larsen, S. J. Curnow, A. M. Leese, P. A. H. Moss, A. D. Hislop, M. Salmon, and A. B. Rickinson
EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15
Blood, July 1, 2006; 108(1): 11 - 18.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Fletcher, M. Vukmanovic-Stejic, P. J. Dunne, K. E. Birch, J. E. Cook, S. E. Jackson, M. Salmon, M. H. Rustin, and A. N. Akbar
Cytomegalovirus-Specific CD4+ T Cells in Healthy Carriers Are Continuously Driven to Replicative Exhaustion
J. Immunol., December 15, 2005; 175(12): 8218 - 8225.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. J. Miles, S. L. Silins, A. G. Brooks, J. E. Davis, I. Misko, and S. R. Burrows
T-cell grit: large clonal expansions of virus-specific CD8+ T cells can dominate in the peripheral circulation for at least 18 years
Blood, December 15, 2005; 106(13): 4412 - 4413.
[Full Text] [PDF]


Home page
J. Immunol.Home page
C. C. Kemball, E. D. H. Lee, V. Vezys, T. C. Pearson, C. P. Larsen, and A. E. Lukacher
Late Priming and Variability of Epitope-Specific CD8+ T Cell Responses during a Persistent Virus Infection
J. Immunol., June 15, 2005; 174(12): 7950 - 7960.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. Curran, O. M. FitzGerald, P. J. Costello, J. M. Selby, D. J. Kane, B. Bresnihan, and R. Winchester
Nucleotide Sequencing of Psoriatic Arthritis Tissue before and during Methotrexate Administration Reveals a Complex Inflammatory T Cell Infiltrate with Very Few Clones Exhibiting Features That Suggest They Drive the Inflammatory Process by Recognizing Autoantigens
J. Immunol., February 1, 2004; 172(3): 1935 - 1944.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
G. T. Belz, H. Liu, S. Andreansky, P. C. Doherty, and P. G. Stevenson
Absence of a functional defect in CD8+ T cells during primary murine gammaherpesvirus-68 infection of I-Ab-/- mice
J. Gen. Virol., January 1, 2003; 84(2): 337 - 341.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. J. Dunne, J. M. Faint, N. H. Gudgeon, J. M. Fletcher, F. J. Plunkett, M. V. D. Soares, A. D. Hislop, N. E. Annels, A. B. Rickinson, M. Salmon, et al.
Epstein-Barr virus-specific CD8+ T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential
Blood, July 18, 2002; 100(3): 933 - 940.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. D. Hislop, N. H. Gudgeon, M. F. C. Callan, C. Fazou, H. Hasegawa, M. Salmon, and A. B. Rickinson
EBV-Specific CD8+ T Cell Memory: Relationships Between Epitope Specificity, Cell Phenotype, and Immediate Effector Function
J. Immunol., August 15, 2001; 167(4): 2019 - 2029.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. D. Bitmansour, S. L. Waldrop, C. J. Pitcher, E. Khatamzas, F. Kern, V. C. Maino, and L. J. Picker
Clonotypic Structure of the Human CD4+ Memory T Cell Response to Cytomegalovirus
J. Immunol., August 1, 2001; 167(3): 1151 - 1163.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. D. Hislop, N. E. Annels, N. H. Gudgeon, A. M. Leese, and A. B. Rickinson
Epitope-specific Evolution of Human CD8+ T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus Infection
J. Exp. Med., April 1, 2002; 195(7): 893 - 905.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.